WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 21-Sep-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 41'7901 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 47'5611 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 11'429  11'358  11'288  11'219  11'152  10'282  10'007  9'869 
Births 130  130  129  128  128  114  120  119 
Surviving infants 130  129  129  128  127  113  119  118 
Pop. less than 5 years 647  643  645  644  646  576  590  600 
Pop. less than 15 years 1'954  1'934  1'919  1'903  1'889  1'806  1'794  1'988 
Female 15-49 years 2'501  2'509  2'515  2'516  2'515  2'458  2'460  2'390 

Number of reported cases

(Click for retrospective incidence data for Belgium)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  367  47  70  39 
Mumps
ChartChart
  13  153  119  228  4'573 
Pertussis
ChartChart
  1'535  2'105  1'203  1'501  1'142 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Belgium)
Vaccine year result method % card seen                                                
BCG         
DTP1          99  99  99*  99*  99*  97 
DTP3          98  98  99  99  99  95  93 
DTP4          93  93  93  92  92 
IPV1          99*  99*  99*  99*  99* 
HepB_BD         
HepB3          97  97  98  98  98  60 
Hib3          97  97  98  98  98  86 
JapEnc         
MCV1          96  96  96  96  96  82  85 
MCV2          85  85  85  85  85 
MenA         
PCV1          98  98  98  98  98 
PCV2          97  97  98  97  97 
PCV3          94  94  94  93  93 
Pol3          98  98  99  99  99  96  95 
Rota1          90  90  91  89  89 
RotaC          87  87  88  86  86 
RCV1          96  96  96  96  96 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Belgium)
DTP1
ChartChart
  99  99  99  99  99  97  97  98 
DTP3
ChartChart
  98  98  99  99  99  95  93  95 
HepB3
ChartChart
  97  97  98  98  98  60 
HepB_BD
 
Hib3
ChartChart
  97  97  98  98  98  86 
MCV1
ChartChart
  96  96  96  96  96  82  85 
MCV2
ChartChart
  85  85  85  85  85 
PCV3
ChartChart
  94  94  94  93  93 
Pol3
  98  98  99  99  99  96  95  99 
RCV1
ChartChart
  96  96  96  96  96  82  85 
RotaC
ChartChart
  87  87  88  86  86 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 43  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepBIPV 8, 12, 16 weeks; 15 months; Yes
DTaPHibHepIPV 8, 12, 16 weeks; 15 months; Yes
DTaPIPV 5-6 years; No or 6 years (Flanders)
HPV 13-14 years; +6 months; Yes or 2 doses at 12 years in Flanders
Influenza_Adult Yes elderly, adults with chronic illness, pregnant women, health care workers, residents living in long-term care facilities, other risk groups
Influenza_Pediatric Yes children with chronic illness
MenC_conj 15 months; No
MMR 12 months; 11-12 years; No 2nd dose at Y10 in Flanders
Pneumo_conj 8, 16 weeks; 12 months; Yes
Rotavirus 8, 12, 16 weeks; Yes 3rd dose depend on vaccine presentation
Tdap 15-16 years; +10 years (x5); No or Y14 (Flanders) and during pregnancy

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2020  2012-2020  2012-2020    2012-2020     
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 43  43    43  43  43  43 
Nº districts with DTP3 coverage >=80% number            
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes    Yes  NA  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    Yes    Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.